<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="natpep1_6s" dataset_id="pht000393.v7" study_name="Framingham Cohort" study_id="phs000007.v30" participant_set="11" date_created="2018/09/17"><description>Natriuretic Peptides, Offspring Cohort Exam 6</description><variable id="phv00055163.v6.p11" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>1582</male><female>1779</female></sex></subject_profile><stats><stat n="3361" nulls="0"/></stats></total></variable><variable id="phv00055163.v6.p11.c1" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>1237</male><female>1419</female></sex></subject_profile><stats><stat n="2656" nulls="0"/></stats></total></variable><variable id="phv00055163.v6.p11.c2" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>342</male><female>357</female></sex></subject_profile><stats><stat n="699" nulls="0"/></stats></total></variable><variable id="phv00055159.v6.p11" var_name="bnp" calculated_type="decimal" units="PG/ML" reported_type=""><description>B-TYPE NATRIURETIC PEPTIDE (PG/ML)</description><total><subject_profile><sex><male>1581</male><female>1779</female></sex></subject_profile><stats><stat n="3360" nulls="1" mean="16.58" sd="23.88" median="8.4" min="4" max="387"/><example count="1036">4</example><example count="23">4.7</example><example count="22">4.5</example><example count="22">4.8</example><example count="22">4.2</example><example count="22">7.9</example><example count="20">5.8</example><example count="19">5.7</example><example count="19">4.4</example><example count="17">5.2</example></stats></total></variable><variable id="phv00055159.v6.p11.c1" var_name="bnp" calculated_type="decimal" units="PG/ML" reported_type=""><description>B-TYPE NATRIURETIC PEPTIDE (PG/ML)</description><total><subject_profile><sex><male>1236</male><female>1419</female></sex></subject_profile><stats><stat n="2655" nulls="1" mean="14.52" sd="19.78" median="7.7" min="4" max="308"/><example count="881">4</example><example count="19">4.2</example><example count="18">4.5</example><example count="18">4.7</example><example count="17">5.8</example><example count="17">4.8</example><example count="16">6</example><example count="16">7.9</example><example count="16">4.4</example><example count="15">4.6</example></stats></total></variable><variable id="phv00055159.v6.p11.c2" var_name="bnp" calculated_type="decimal" units="PG/ML" reported_type=""><description>B-TYPE NATRIURETIC PEPTIDE (PG/ML)</description><total><subject_profile><sex><male>342</male><female>357</female></sex></subject_profile><stats><stat n="699" nulls="0" mean="24.36" sd="34.32" median="11.5" min="4" max="387"/><example count="154">4</example><example count="7">5.9</example><example count="6">9.7</example><example count="6">13.4</example><example count="6">5.7</example><example count="6">7.9</example><example count="5">5.2</example><example count="5">5.4</example><example count="5">11.5</example><example count="5">8.3</example></stats></total></variable><variable id="phv00055160.v6.p11" var_name="adrenomedullin" calculated_type="decimal" units="MICROMOL/L" reported_type=""><description>ADRENOMEDULLIN (MICROMOL/L)</description><total><subject_profile><sex><male>1571</male><female>1776</female></sex></subject_profile><stats><stat n="3347" nulls="14" mean="12.3" sd="4.462" median="11.8" min="2" max="76.4"/><example count="85">2</example><example count="54">11.3</example><example count="53">11</example><example count="52">12.1</example><example count="51">10.8</example><example count="50">12.2</example><example count="49">11.7</example><example count="49">10.3</example><example count="49">11.8</example><example count="47">9.6</example></stats></total></variable><variable id="phv00055160.v6.p11.c1" var_name="adrenomedullin" calculated_type="decimal" units="MICROMOL/L" reported_type=""><description>ADRENOMEDULLIN (MICROMOL/L)</description><total><subject_profile><sex><male>1229</male><female>1417</female></sex></subject_profile><stats><stat n="2646" nulls="10" mean="12.09" sd="4.328" median="11.7" min="2" max="76.4"/><example count="62">2</example><example count="45">12.1</example><example count="45">10.3</example><example count="44">11</example><example count="42">11.1</example><example count="41">11.3</example><example count="41">11.8</example><example count="40">10.8</example><example count="39">11.7</example><example count="39">10.5</example></stats></total></variable><variable id="phv00055160.v6.p11.c2" var_name="adrenomedullin" calculated_type="decimal" units="MICROMOL/L" reported_type=""><description>ADRENOMEDULLIN (MICROMOL/L)</description><total><subject_profile><sex><male>339</male><female>356</female></sex></subject_profile><stats><stat n="695" nulls="4" mean="13.1" sd="4.865" median="12.6" min="2" max="39.4"/><example count="23">2</example><example count="13">11.3</example><example count="12">12.2</example><example count="11">13.5</example><example count="11">10.1</example><example count="11">10.8</example><example count="10">10.7</example><example count="10">11.7</example><example count="10">13.3</example><example count="10">13.1</example></stats></total></variable><variable id="phv00055161.v6.p11" var_name="nt_anp" calculated_type="decimal" units="PMOL/L" reported_type=""><description>N-TERMINAL PRO-ATRIAL NATRIURETIC PEPTIDE (PMOL/L)</description><total><subject_profile><sex><male>1575</male><female>1776</female></sex></subject_profile><stats><stat n="3351" nulls="10" mean="389.6" sd="265.7" median="323" min="94" max="3820"/><example count="78">94</example><example count="18">247</example><example count="15">302</example><example count="15">188</example><example count="15">203</example><example count="14">226</example><example count="14">320</example><example count="14">137</example><example count="14">248</example><example count="13">295</example></stats></total></variable><variable id="phv00055161.v6.p11.c1" var_name="nt_anp" calculated_type="decimal" units="PMOL/L" reported_type=""><description>N-TERMINAL PRO-ATRIAL NATRIURETIC PEPTIDE (PMOL/L)</description><total><subject_profile><sex><male>1231</male><female>1416</female></sex></subject_profile><stats><stat n="2647" nulls="9" mean="364.9" sd="224.8" median="312" min="94" max="2620"/><example count="68">94</example><example count="13">320</example><example count="12">226</example><example count="12">280</example><example count="12">302</example><example count="12">269</example><example count="12">247</example><example count="12">219</example><example count="12">185</example><example count="11">307</example></stats></total></variable><variable id="phv00055161.v6.p11.c2" var_name="nt_anp" calculated_type="decimal" units="PMOL/L" reported_type=""><description>N-TERMINAL PRO-ATRIAL NATRIURETIC PEPTIDE (PMOL/L)</description><total><subject_profile><sex><male>341</male><female>357</female></sex></subject_profile><stats><stat n="698" nulls="1" mean="482.8" sd="368.6" median="383" min="94" max="3820"/><example count="10">94</example><example count="6">247</example><example count="5">188</example><example count="5">222</example><example count="5">232</example><example count="5">449</example><example count="4">316</example><example count="4">1370</example><example count="4">327</example><example count="4">218</example></stats></total></variable><variable id="phv00055162.v6.p11" var_name="idtype" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>1582</male><female>1779</female></sex></subject_profile><stats><stat n="3361" nulls="0" mean_count="3361" median_count="3361" min_count="3361" max_count="3361"/><enum code="1" count="3361">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00055162.v6.p11.c1" var_name="idtype" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>1237</male><female>1419</female></sex></subject_profile><stats><stat n="2656" nulls="0" mean_count="2656" median_count="2656" min_count="2656" max_count="2656"/><enum code="1" count="2656">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00055162.v6.p11.c2" var_name="idtype" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>342</male><female>357</female></sex></subject_profile><stats><stat n="699" nulls="0" mean_count="699" median_count="699" min_count="699" max_count="699"/><enum code="1" count="699">OFFSPRING GROUP</enum></stats></total></variable></data_table>
